This site uses cookies to provide you with more responsive and personalized service and to collect certain information about your use of the site. You can change your cookie settings through your browser. If you continue without changing your settings, you agree to our use of cookies. See our Privacy Policy for more information.
Has the Federal Drug Administration done its due diligence in approving the abortion pill Mifepristone? This is what is being considered in the Supreme Court as this drug regimen continues to be distributed to women across the U.S. On Friday, we'll hear from a doctor that has done extensive research on the drug and is going to share what she discovered from her study. Dr. Ingrid Skop, is the director of medical affairs at the Lozier Institute and is a practicing, board-certified OB/GYN who has delivered more than 5,000 babies and has personally treated many abortion pill-related complications. Be listening for this important information on the dangers to women's health that are being overlooked in this political battle.
Ingrid Skop, M.D., FACOG, is Vice President and Director of Medical Affairs for Charlotte Lozier Institute, leveraging more than 25 years of experience as a practicing obstetrician-gynecologist to support research and policies that respect the dignity of every human life. Prior to joining Charlotte Lozier Institute, Dr. Skop served in private practice in San Antonio, where she delivered more than 5,000 babies and personally cared for many women who had been harmed, physically and emotionally, from complications due to abortion.